𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intelligence outcome in children with shunted hydrocephalus of different etiology

✍ Scribed by Daria Riva; Nicoletta Milani; Cesare Giorgi; Chiara Pantaleoni; Carla Zorzi; Monica Devoti


Publisher
Springer
Year
1994
Tongue
English
Weight
347 KB
Volume
10
Category
Article
ISSN
0256-7040

No coin nor oath required. For personal study only.

✦ Synopsis


Children with shunted hydrocephalus of differing etiologies were assessed. There was a more selective loss of non-verbal than of verbal intelligence. The verbal and visuo-perceptual abilities were affected by different sets of variables. Variables related to the hydrocephalus had no effects, while associated supratentorial malformations significantly affected non-verbal functions.


πŸ“œ SIMILAR VOLUMES


Functions and complications of shunts in
✍ W. Serlo; E. Fernell; E. Heikkinen; H. Anderson; L. Wendt πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 285 KB

Shunt function and complications in different etiologies of childhood hydrocephalus were studied in a series of 306 patients involving 1102 shunt operations. Shunts in patients with hydrocephalus caused by neoplasms proved to be most prone to shunt complications. The patency time for shunts in these

Doppler flow velocities in children with
✍ I. K. Pople πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 195 KB

Doppler flow velocities in the middle cerebral artery of children with blocked cerebrospinal fluid shunts show changes that can be used as a non-invasive method for assessing shunt function. The velocities also change with age, and the purpose of this study was to define a reference range of values

Outcome of acute lymphoblastic leukemia
✍ Ishii, Eiichi ;Eguchi, Haruhiko ;Matsuzaki, Akinobu ;Koga, Hiroyuki ;Yanai, Fumi πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 177 KB

## Abstract ## Background In our previous studies, the outcome of high‐risk ALL was still poor. In the present study, all children with ALL were classified into three groups and treated with a new regimen (AL90). ## Patients and Methods Between 1990 and 1996, 220 children with ALL, treated with